Recombinant epidermal growth factor (AMMS)

外用重组人表皮生长因子(中国人民解放军军事医学科学院生物工程研究所)

Report date: 2022/01/14 13:23:58

Base Information

Drug NameRecombinant epidermal growth factor (AMMS)
Drug Alias Name艾唯尔
ClassificationBiologics > Protein drugs > Recombinant protein > Recombinant cytokines
Mechanisms of ActionEpidermal growth factor receptor erbB1 modulators
TargetsEpidermal growth factor receptor erbB1
Therapy Area/IndicationsCorneal Injuries
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPending (NDA/BLA)
Highest Status in ChinaPending
China Registration ClassClass 1 therapeutic biologic in China

Develop Information

Other Information

ATC CodeN/A
Related LinksN/A